Wall Street Zen Downgrades Allovir (NASDAQ:KLRS) to Sell
Wall Street Zen downgraded shares of Allovir (NASDAQ:KLRS – Free Report) from a hold rating to a sell rating in a research report report published on Saturday morning. Allovir Stock Performance Shares of KLRS opened at $2.79 on Friday. About Allovir (Get Free Report) Allovir, Inc, a clinical-stage cell therapy company, engages in the research […]
Wall Street Zen downgraded shares of Allovir (NASDAQ:KLRS – Free Report) from a hold rating to a sell rating in a research report report published on Saturday morning. Allovir Stock Performance Shares of KLRS opened at $2.79 on Friday. About Allovir (Get Free Report) Allovir, Inc, a clinical-stage cell therapy company, engages in the research […]
